期刊文献+

胆结石术后辅用通腑利胆汤治疗胆管炎的疗效观察

Clinical Observation of Tongfu Lidan Decoction in the Treatment of Cholangitis after Gallstone Surgery
下载PDF
导出
摘要 目的观察胆结石术后辅用通腑利胆汤治疗胆管炎的临床疗效。方法选取68例胆结石并发胆管炎患者临床资料进行回顾分析,按照随机数字表法将患者分为人数均等的两组(各34例);其中对照组患者接受常规西药治疗,观察组患者在此基础上使用通腑利胆汤治疗。结果治疗后两组患者临床症状均有显著改善,其中观察组患者腹痛缓解时间、退热时间显著短于对照组,P<0.05;治疗1个疗程后患者血清胆红素水平显著下降,观察组下降程度更为显著,P<0.05;本次治疗效果良好,其中观察组治疗总有效率为97.06%,对照组治疗总有效率为82.35%,显著观察组疗效更高,P<0.05。结论临床使用通腑利胆汤辅助治疗胆结石术后胆管炎,可显著控制患者临床症状并显著缓解,具有推广使用价值。 OBJECTIVE To observe the clinical effect of Tongfu Lidan Decoction in the treatment of cholangitis after gallstone surgery. METHODS The clinical data about 68 patients of gallstone associated with cholangitis was retrospectively analyzed. The patients were randomly and equally divided into two groups, 34 cases each group. The control group adopted the conventional western drug therapy;on this basis, the observation group took Tongfu Lidan Decoction. RESULTS After treatment, the clinical symptoms of two groups were greatly improved. The time of relie- ving stomachache and bringing down the fever of observation group was shorter than that of control group (P 〈 0. 05 ) :after one course .the serum bilirubin content of observation group was even lower than that of control group ( P〈 0.05) ; the treatment effect was favorable. The total effective rate of observation group (97.06%) was higher than that of control group (82.35%) ( P 〈 0. 05 ). CONCLUSION The adjuvant therapy of Tongfu Lidan Decoction
作者 赖奕辉
出处 《海峡药学》 2016年第1期92-94,共3页 Strait Pharmaceutical Journal
关键词 通腑利胆汤 胆结石术 胆管炎 疗效观察 Tongfu lidan secoction Gallstone aurgery Cholangitis Clinical observation
  • 相关文献

参考文献6

二级参考文献52

  • 1王永清.头孢曲松钠导致小儿假性胆石症一例[J].中华儿科杂志,2005,43(4):251-251. 被引量:20
  • 2李锐,韩本立,李昆,彭志明,段恒春.急性胆管炎早期Kupffer细胞激活对肝细胞能量代谢的影响[J].中华实验外科杂志,1995,12(6):321-322. 被引量:6
  • 3黄鹤光,殷风峙,石铮.重症急性胆管炎伴肝肾功能不全时的肝肾病理改变[J].中华实验外科杂志,1996,13(5):298-299. 被引量:10
  • 4陈美南,李富玉.清热利胆消石汤治疗胆囊炎伴胆结石100例疗效观察[J].医学信息(西安上半月),2006,19(10):1888-1888. 被引量:2
  • 5Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology, 1991, 100 : 1665-1670.
  • 6Schaad UB, Tscheippeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis, 1986, 5 : 708-710.
  • 7Biner B, Oner N, Celtik C, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound, 2006, 34: 217- 222.
  • 8Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone- associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology, 1990,99: 1772-1778.
  • 9Xia Y, Lambert KJ, Schteingart CD, et al. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology, 1990, 99: 454-465.
  • 10Arpacik M, Ceran C, Kaya T, et al. Effects of ceftriaxone sodium on in vitro gallbladder contractility in guinea pigs. J Surg Res, 2004, 122: 157-161.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部